Patents
Patents for C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
06/2005
06/09/2005US20050123473 Diagnosis, therapy, image of celluloar disorders; antitumor agents
06/09/2005US20050120494 Triazacyclononane derivatives substituted on at least one of the nitrogen atoms with a substituted or unsubstituted 4'-aminophenyl group, for dyeing keratin fibres
06/02/2005WO2005049585A1 Macrocyclic lactams and pharmaceutical use thereof
06/02/2005CA2544751A1 Macrocyclic lactams and pharmaceutical use thereof
06/01/2005CN1203899C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy
04/2005
04/20/2005EP1443934B1 Benzotriazepines as gastrin and cholecystokinin receptor ligands
04/06/2005CN1195733C Method for preparation of aryl alkyl hydrogen peroxide
03/2005
03/30/2005EP1518860A1 Triazacyclononane derivatives substituted on at least one of the nitrogene atoms by a 4-aminophenyle group for dyeing keratinic fibres
03/30/2005EP1091942B1 Potassium channel blocking agents
03/09/2005EP1511476A2 Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same
03/03/2005WO2005019211A2 Biaryl heterocyclic compounds and methods of making and using the same
03/03/2005CA2528089A1 Biaryl heterocyclic compounds and methods of making and using the same
02/2005
02/24/2005US20050043509 Peptoid compounds
02/24/2005US20050043317 Biaryl heterocyclic compounds and methods of making and using the same
02/23/2005EP1507526A2 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
02/23/2005CN1585643A Benzotriazepines as gastrin and cholecystokinin receptor ligands
02/17/2005US20050038249 metal complexes used as prodrugs that may be activated under hypoxic conditions by enzymes or by radiotherapy for treatment of cancer
02/03/2005US20050026911 Benzotriazapinone salts and methods for using same
01/2005
01/19/2005CN1185242C Ligand and complex for catalytically bleaching substate
12/2004
12/30/2004US20040267009 Reacting a mixture of tris(2-aminoethyl)amine with glyoxal in the presence of water, a water miscible solvent and a tertiary amine with cooling to a temperature of about -30 degrees C. or less, wherein the glyoxal is added slowly to the mixture
12/14/2004CA2225453C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
12/01/2004EP1480999A2 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
11/2004
11/25/2004WO2004101533A1 1, 3, 4-benzotriazepin-2-one salts and their use as cck receptor ligands
11/18/2004WO2004098610A1 Benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligands
11/18/2004WO2004098609A1 Benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligands
11/04/2004US20040220164 Triaza compound immunoregulatory agents
09/2004
09/16/2004WO2003095398A3 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
08/2004
08/18/2004EP0619813B1 Linked cyclic polyamines with activity against hiv
08/11/2004EP1443934A1 Benzotriazepines as gastrin and cholecystokinin receptor ligands
07/2004
07/22/2004WO2003101919A3 Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same
07/15/2004US20040138195 Activation using enzyme or ionizing radiation
05/2004
05/19/2004EP0717736B1 Phosphorus derivatives to treat aids
05/06/2004EP0998476B1 1,4,7,10-tetraazabicyclo 8.2.2]tetradecan-2-one, a process for the preparation thereof and the use thereof for the preparation of tetraazamacrocycles
04/2004
04/28/2004EP1412336A1 Peptoid compounds
04/07/2004CN1144793C Polar-substituted hydrocarbons
03/2004
03/25/2004WO2003072528A3 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
03/18/2004WO2002080856A3 Triaza compound immunoregulatory agents
03/04/2004US20040044199 Cyclic urea compounds and preparation thereof
03/03/2004CN1140503C Triazepiones, compound process for their preparation and their therapeutic application
02/2004
02/26/2004US20040038962 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia
02/11/2004EP0835125B1 Cd4-derived peptides that inhibit immune responses
02/11/2004EP0755385B1 Chelant compounds
01/2004
01/21/2004EP1382332A1 Method for inhibiting bacterial or fungal growth using a polyamine derivative as complexing agent
01/07/2004CN1466579A Process for preparation of 1-1 protected n ring nitrogen containing cyclic polyamines and products thereof
12/2003
12/18/2003US20030232788 Inhibitors of interleukin-1 beta converting enzyme and related proteases
12/17/2003CN1462269A Fused azepine drivatives and their use as antidiuretic agents
12/16/2003CA2178272C Antiviral monocyclic polyamines
12/11/2003WO2003101919A2 Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same
12/11/2003US20030228262 Diagnosis, therapy, image of celluloar disorders; antitumor agents
12/09/2003US6660832 Macrocyclic compounds and preparation methods thereof
11/2003
11/26/2003EP1363908A1 ANTI-CANCER 2,3-DIHYDRO-1H-PYRROLO 3,2-f]QUINOLINE COMPLEXES OF COBALT AND CHROMIUM
11/25/2003US6653506 Solubilizing material except for nitramines in acid solution; removing effluent; neutralization; zero waste; cyclotetramethylene tetranitramine (HMX) and cyclotetramethylene trinitramine (RDX)
11/20/2003WO2003095398A2 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
11/20/2003CA2485167A1 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
11/11/2003US6646122 Ligand and complex for catalytically bleaching a substrate
09/2003
09/10/2003EP1259522B1 Ligand and complex for catalytically bleaching a substrate
09/04/2003WO2003072528A2 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
09/04/2003CA2475653A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
08/2003
08/26/2003US6610641 Transition metal complex
07/2003
07/23/2003CN1431200A Compound of phycocyania of blue-green algae, its preparing method and usage
07/09/2003CN1429231A Ligand and complex for catalytically bleaching substate
07/08/2003CA2095615C Polyazamacrocyclic compounds for complexation of metal ions
07/02/2003EP1322626A1 Process for preparation of n-1 protected n ring nitrogen containing cyclic polyamines and products thereof
06/2003
06/25/2003CN1426451A Composition and method for bleaching substrate
06/24/2003US6583182 Atomic numbers 21-30 are components of enzymes required for nucleic acid replication; substituted polyaza compounds inhibit cell replication by decreaseing bioavailability of iron or copper
06/10/2003US6576791 Local anesthetic compounds and uses
05/2003
05/27/2003US6569880 Bis(benzimidazole) derivatives serving as potassium blocking agents
05/22/2003WO2003041714A1 Benzotriazepines as gastrin and cholecystokinin receptor ligands
05/22/2003CA2466955A1 Benzotriazepines as gastrin and cholecystokinin receptor ligands
05/21/2003EP1047668B1 Triazepinones, process for their preparation and their therapeutic application
05/06/2003US6559303 Bridgehead atoms are bonded to one or more bridges that interconnect one or more ring systems thereby forming a large cyclic structure. Located in each bridge are two or more nitrogenous moieties that are derivatized with chemical
05/02/2003EP1305299A1 Cyclic polyamine compounds for cancer therapy
05/01/2003WO2001096318A8 Cyclic urea compounds and preparation thereof
04/2003
04/17/2003US20030072715 Cyclic polyamine compounds for cancer therapy
04/08/2003US6545147 Bleaching-active metal complexes
03/2003
03/26/2003EP1294698A1 Fused azepine derivatives and their use as antidiuretic agents
03/12/2003EP1289968A1 Cyclic urea compounds and preparation thereof
01/2003
01/15/2003EP0722442B1 Polyazacycloalkanes as dichelants
01/15/2003CN1391577A Pharmaceutical compositions comprising metal complexes
01/14/2003CA2246758C Peptidomimetic inhibitors of cathepsin d and plasmepsins i and ii
01/09/2003WO2003002545A1 Peptoid compounds
12/2002
12/25/2002CN1387562A Composition and method for bleaching substrate
12/17/2002US6495681 Local anesthetic compounds and uses
12/11/2002EP0981521B1 Novel macrocyclic compounds as metalloprotease inhibitors
12/03/2002US6489472 Process for preparation of N-1 protected N ring nitrogen containing cyclic polyamines and products thereof
11/2002
11/27/2002EP1259588A2 Composition and method for bleaching a substrate
11/27/2002EP1259522A1 Ligand and complex for catalytically bleaching a substrate
10/2002
10/22/2002US6469162 Compounds with chelation affinity and selectivity for first transition series elements: use in medical therapy and diagnosis
10/17/2002WO2002080856A2 Triaza compound immunoregulatory agents
09/2002
09/26/2002US20020137784 Guanidine derivatives
09/17/2002US6452049 Recovering nitramines and reformulation of by-products
08/2002
08/13/2002CA2216633C Synthesis of bis-indolylmaleimides
08/01/2002WO2002059122A1 ANTI-CANCER 2,3-DIHYDRO-1H-PYRROLO[3,2-f]QUINOLINE COMPLEXES OF COBALT AND CHROMIUM
08/01/2002CA2435653A1 Anti-cancer 2,3-dihydro-1h-pyrrolo[3,2-f]quinoline complexes of cobalt and chromium
07/2002
07/17/2002EP1223166A1 Linked cyclic polyamines with activity against hiv.
05/2002
05/16/2002US20020058807 Process for preparation of N-1 protected N ring nitrogen containing cyclic polyamines and products thereof
05/15/2002EP0809504B1 Anti-viral triazacyclododecane
04/2002
04/30/2002US6380180 Potassium channel blocking agents
04/25/2002US20020049246 Benzimidazole compounds for treatment of asthma, vasospasm, memory loss, migraine and others diseases associated with potassium channels
04/25/2002US20020049190 Useful in binding nitric oxide; inhibiting tumor growth
1 2 3 4 5 6 7 8